Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 2, 2008, Pages 215-218

  Smilevska, Tatjana ^a   Tsakou, Eugenia ^b   Hadzidimitriou, Anastasia ^a   Bikos, Vasilis ^a   Stavroyianni, Niki ^a   Laoutaris, Nikolaos ^b   Fassas, thanasios ^a   nagnostopoulos, Achilles ^a   Papadaki, Theodora ^c   Belessi, Chrysoula ^b   Stamatopoulos, Kostas ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b GENERAL HOSPITAL OF NIKEA   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Follicular lymphoma; Immunoglobulin; Kappa light chains; Somatic hypermutation

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN KAPPA CHAIN;

ARTICLE; B CELL LYMPHOMA; COMPARATIVE STUDY; FOLLICULAR LYMPHOMA; GENE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN KAPPA GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC HYPERMUTATION;

B-LYMPHOCYTES; CLONE CELLS; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; LYMPHOMA, FOLLICULAR; RECEPTORS, ANTIGEN, B-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 48749100416     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.06.002     Document Type: Article

References (32)

1. Bende R.J., Smit L.A., and van Noesel C.J. Molecular pathways in follicular lymphoma. Leukemia 21 (2007) 18-29
2. Stamatopoulos K., Kosmas C., Belessi C., et al. Molecular insights into the immunopathogenesis of follicular lymphoma. Immunol Today 21 (2000) 298-305
3. de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23 (2005) 6358-6363
4. Dave S., Wright G., Tan B., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351 (2004) 2159-2169
5. Farinha P., Masoudi H., Skinnider F., et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage content is an independent predictor of survival in follicular lymphoma. Blood 106 (2005) 2169-2174
6. Glas A.M., Knoops L., Delahaye L., et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 25 (2007) 390-398
7. Staudt L. A closer look at follicular lymphoma. N Engl J Med 356 (2007) 741-742
8. Zhu D., McCarthy H., Ottensmeier C., et al. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99 (2002) 2562-2568
9. McCann K., Johnson P., Stevenson F., and Ottensmeier C. Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?. Leukemia 20 (2006) 530-534
10. Stamatopoulos K., Kosmas C., Papadaki T., et al. Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol 96 (1997) 132-146
11. Noppe S.M., Heirman C., Bakkus M.H., et al. The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol 107 (1999) 625-640
12. Aarts W., Bende R., Steenbergen E., et al. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 95 (2000) 2922-2929
13. Kosmas C., Stamatopoulos K., Papadaki T., et al. Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma. Immunol Rev 162 (1998) 281-292
14. Belessi C., Stamatopoulos K., Stavroyianni N., et al. Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma. Leukemia 15 (2001) 1772-1778
15. Hardianti M.S., Tatsumi E., Syampurnawati M., et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 18 (2004) 826-831
16. Stamatopoulos K., Belessi C., Hadzidimitriou A., et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106 (2005) 3575-3583
17. Belessi C., Stamatopoulos K., Hadzidimitriou A., et al. Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia. Mol Med 11 (2005) 52-58
18. Langerak A.W., and van Dongen J.J. Recombination in the human IGK locus. Crit Rev Immunol 26 (2006) 23-42
19. Stamatopoulos K., Belessi C., Papadaki T., et al. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma. Mol Med 10 (2004) 89-95
20. Hadzidimitriou A., Stamatopoulos K., Belessi C., et al. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases. Haematologica 91 (2006) 781-787
21. Lefranc M.P., Giudicelli V., Kaas Q., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 33 (2005) Database Issue:D593-597
22. Brezinschek H.P., Foster S., Dorner T., et al. Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol 160 (1998) 4762-4767
23. de Wildt R., Hoet R., van Venrooij W., et al. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 285 (1999) 895-901
24. de Wildt R., Tomlinson I., van Venrooij W., et al. Comparable heavy and light chain pairings in normal and systemic lupus erythematosus IgG(+) B cells. Eur J Immunol 30 (2000) 254-261
25. Hoet R., Pieffers M., Stassen M., et al. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol 163 (1999) 3304-3312
26. Foster S., Brezinschek H., Brezinschek R., and Lipsky P. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 99 (1997) 1614-1627
27. Juul L., Hougs L., Andersen V., et al. The normally expressed kappa immunoglobulin light chain gene repertoire and somatic mutations studied by single-sided specific polymerase chain reaction (PCR); frequent occurrence of features often assigned to autoimmunity. Clin Exp Immunol 109 (1997) 194-203
28. Lefranc M.P. Nomenclature of the human immunoglobulin kappa (IGK) genes. Exp Clin Immunogenet 18 (2001) 161-174
29. Martin T., Blaison G., Levallois H., and Pasquali J. Molecular analysis of the V kappa III-J kappa junctional diversity of polyclonal rheumatoid factors during rheumatoid arthritis frequently reveals N addition. Eur J Immunol 22 (1992) 1773-1779
30. Xu J., and Davis M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13 (2000) 37-45
31. Wardemann H., Yurasov S., Schaefer A., et al. Predominant autoantibody production by early human B cell precursors. Science 301 (2003) 1374-1377
32. Pommie C., Levadoux S., Sabatier R., Lefranc G., and Lefranc M.P. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit 17 (2004) 17-32